| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $54.1M | +184.6% |
| SG&A Expense | $14.2M | +75.4% |
| Operating Income | -$68.3M | -151.9% |
| Pre-tax Income | -$65.4M | -139.7% |
| Income Tax | $3.7M | — |
| Net Income | -$69.1M | -153.3% |
| EPS (Basic) | -$4.42 | +85.4% |
| EPS (Diluted) | -$4.42 | +85.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $181.8M | +36.8% |
| Current Assets | $186.1M | +32.9% |
| Total Assets | $217.4M | +51.4% |
| Current Liabilities | $18.8M | +82.4% |
| Total Liabilities | $37.8M | +258.5% |
| Stockholders' Equity | $179.6M | +659.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.3M | -162.2% |
| Capital Expenditures | $3.8M | +651.0% |
| Investing Cash Flow | -$3.8M | -651.0% |
| Financing Cash Flow | $112.2M | -24.0% |
| Free Cash Flow | -$63.0M | -172.8% |